Rigel Pharmaceuticals
RIGL
#6965
Rank
โ‚ฌ0.59 B
Marketcap
32,22ย โ‚ฌ
Share price
-0.22%
Change (1 day)
89.50%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): โ‚ฌ0.10 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.29 Billion. In 2025 the company made an earning of โ‚ฌ0.11 Billion, an increase over its 2024 earnings that were of โ‚ฌ23.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.10 B-3.13%
2025 โ‚ฌ0.11 B391.35%
2024 โ‚ฌ23.05 M-244.27%
2023 -โ‚ฌ15.98 Million-66.79%
2022 -โ‚ฌ48.12 Million340.73%
2021 -โ‚ฌ10.92 Million-56.15%
2020 -โ‚ฌ24.9 Million-57.34%
2019 -โ‚ฌ58.38 Million-7.66%
2018 -โ‚ฌ63.22 Million-9.47%
2017 -โ‚ฌ69.83 Million24.46%
2016 -โ‚ฌ56.11 Million23.63%
2015 -โ‚ฌ45.38 Million-43.29%
2014 -โ‚ฌ80.03 Million2.5%
2013 -โ‚ฌ78.08 Million
2010 โ‚ฌ33.2 M-133.97%
2009 -โ‚ฌ97.74 Million-18.49%
2008 -โ‚ฌ0.12 Billion71.91%
2007 -โ‚ฌ69.75 Million84.74%
2006 -โ‚ฌ37.76 Million-10.17%
2005 -โ‚ฌ42.03 Million-15.73%
2004 -โ‚ฌ49.88 Million39.29%
2003 -โ‚ฌ35.81 Million10.3%
2002 -โ‚ฌ32.47 Million48.3%
2001 -โ‚ฌ21.9 Million-2.13%
2000 -โ‚ฌ22.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚ฌ7.96 B 6,951.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.86 B 11,278.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚ฌ96.76 Million-185.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-โ‚ฌ0.12 Billion-201.34%๐Ÿ‡บ๐Ÿ‡ธ USA